Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific ADGRG3 GPR97, Pb99, PGR26 ENSG00000182885 Adhesion G protein-coupled receptor G3 16 57668187-57689378 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA040469 Uncertain Group enriched 5 appendix: 19.4;bone marrow: 86.7 adipose tissue: 9.6 CCL7 FIC, MARC, MCP-3, MCP3, NC28, SCYA6, SCYA7 ENSG00000108688 Chemokine (C-C motif) ligand 7 17 34270221-34272242 Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 8 appendix: 3.6;bone marrow: 15.3 gallbladder: 1.1 CLEC4D CD368, CLECSF8, Mpcl ENSG00000166527 C-type lectin domain family 4, member D 12 8509475-8522366 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004906 Approved Group enriched 6 appendix: 10.7;bone marrow: 42.9 cervix: 4.8 FCN1 FCNM ENSG00000085265 Ficolin (collagen/fibrinogen domain containing) 1 9 134905890-134917963 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000685, HPA001295, CAB016760 Supported Group enriched 5 appendix: 331.6;bone marrow: 635.8 spleen: 96.4 PRRT4 ENSG00000224940 Proline-rich transmembrane protein 4 7 128350325-128361685 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA046373, HPA052681 Uncertain Approved Nucleoplasm
Peroxisomes
Plasma membrane Group enriched 12 adipose tissue: 15.7;bone marrow: 41.2 cerebral cortex: 2.3 SRGN PPG, PRG, PRG1 ENSG00000122862 Serglycin 10 69088106-69104811 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000759 Supported Group enriched 6 appendix: 1146.8;bone marrow: 5150.0 gallbladder: 510.5 AC013286.1 ENSG00000281042 10 76350749-76351228 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Group enriched 31 bone marrow: 1.3;epididymis: 4.7 adipose tissue: 0.0 AC018755.18 ENSG00000268500 19 51612091-51646889 Predicted membrane proteins Evidence at transcript level Evidence at transcript level HPA009085 Approved Group enriched 5 appendix: 7.3;bone marrow: 14.2;lymph node: 3.6;spleen: 5.0 urinary bladder: 1.4 ACSL6 ACS2, FACL6, KIAA0837, LACS2, LACS5 ENSG00000164398 Acyl-CoA synthetase long-chain family member 6 5 131949973-132012243 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA040470 Uncertain Group enriched 6 bone marrow: 18.0;cerebral cortex: 62.1;parathyroid gland: 22.1;seminal vesicle: 28.7;testis: 51.2 adrenal gland: 6.5 ADD2 ADDB ENSG00000075340 Adducin 2 (beta) 2 70607618-70768225 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009796, HPA034509, HPA034510 Supported Approved Nucleoplasm
Plasma membrane
Cytosol Group enriched 10 bone marrow: 40.3;cerebral cortex: 44.8 testis: 4.1 CA1 Car1 ENSG00000133742 Carbonic anhydrase I 8 85327608-85379014 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006558, CAB025790 Supported Group enriched 31 bone marrow: 1219.6;colon: 1039.5;rectum: 2348.0 smooth muscle: 49.1 CAMP CAP18, FALL-39, FALL39, LL37 ENSG00000164047 Cathelicidin antimicrobial peptide 3 48223347-48225491 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB015949, CAB016522, HPA029874 Supported Group enriched 99 bone marrow: 1343.7;epididymis: 324.9 lymph node: 8.4 CCL3L3 MGC12815 ENSG00000276085 Chemokine (C-C motif) ligand 3-like 3 17 36194869-36196758 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 8 bone marrow: 7.4;gallbladder: 1.5 lymph node: 0.5 CD177 HNA2A, NB1, PRV1 ENSG00000204936 CD177 molecule 19 43353659-43363172 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA041820, HPA046601 Supported Group enriched 16 bone marrow: 193.4;colon: 159.0;prostate: 110.8;rectum: 184.1 appendix: 10.0 CEACAM4 CGM7 ENSG00000105352 Carcinoembryonic antigen-related cell adhesion molecule 4 19 41618971-41627074 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 appendix: 6.8;bone marrow: 14.0;spleen: 9.1 adipose tissue: 1.7 CEACAM6 CD66c, NCA ENSG00000086548 Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) 19 41750977-41772208 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008370, HPA011041 Supported Group enriched 6 bone marrow: 110.9;colon: 184.1;esophagus: 174.2;gallbladder: 190.2;lung: 406.1;rectum: 236.9 appendix: 38.9 CHIT1 CHI3, CHIT ENSG00000133063 Chitinase 1 (chitotriosidase) 1 203212827-203273641 Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010575 Approved Group enriched 9 bone marrow: 31.3;breast: 10.7;cervix, uterine: 13.4;lung: 53.2;lymph node: 21.5 prostate: 2.9 DPPA4 FLJ10713 ENSG00000121570 Developmental pluripotency associated 4 3 109326141-109337572 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB020678, HPA035249, HPA035250 Supported Group enriched 8 bone marrow: 2.8;placenta: 3.0;testis: 7.7 tonsil: 0.5 FAM129C BCNP1, FLJ39802 ENSG00000167483 Family with sequence similarity 129, member C 19 17523301-17553839 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043277 Approved Group enriched 15 appendix: 14.5;bone marrow: 11.3;lymph node: 28.5;spleen: 37.6;tonsil: 9.7 gallbladder: 1.3 FAM178B LOC51252 ENSG00000168754 Family with sequence similarity 178, member B 2 96875882-96986592 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA042516, HPA062110 Uncertain Uncertain Nuclear speckles
Golgi apparatus Group enriched 5 bone marrow: 11.4;epididymis: 6.6;spleen: 17.0;testis: 7.4 fallopian tube: 2.0 FAM221B C9orf128 ENSG00000204930 Family with sequence similarity 221, member B 9 35816391-35828747 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA023011, HPA026577 Uncertain Group enriched 6 bone marrow: 2.4;testis: 10.4 prostate: 1.1 G0S2 ENSG00000123689 G0/G1 switch 2 1 209675420-209676388 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 5 adipose tissue: 956.4;bone marrow: 939.4;skeletal muscle: 240.6 appendix: 140.8 GJB6 CX30, DFNA3, ED2, EDH, HED ENSG00000121742 Gap junction protein, beta 6, 30kDa 13 20221971-20232395 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014846 Supported Cell Junctions Group enriched 5 bone marrow: 47.6;cerebral cortex: 39.6;esophagus: 150.3;skin: 32.0 tonsil: 12.7 HBA2 HBA-T2 ENSG00000188536 Hemoglobin, alpha 2 16 172847-173710 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB038417, HPA043780 Supported Group enriched 26 bone marrow: 18412.0;placenta: 4269.5 spleen: 435.5 HBQ1 HBQ ENSG00000086506 Hemoglobin, theta 1 16 180453-181181 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA062473 Supported Approved Lipid droplets Group enriched 8 bone marrow: 14.7;cerebral cortex: 3.0 placenta: 1.1 HBZ HBZ-T1, HBZ1 ENSG00000130656 Hemoglobin, zeta 16 152687-154503 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 12 bone marrow: 2.4;placenta: 1.0;testis: 3.9 skin: 0.2 HEMGN CT155, EDAG, NDR ENSG00000136929 Hemogen 9 97926791-97944856 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019572, HPA019604, HPA019606 Supported Group enriched 14 bone marrow: 142.0;testis: 87.7 placenta: 8.1 HIST1H2BB H2B/f, H2BFF ENSG00000276410 Histone cluster 1, H2bb 6 26043227-26123904 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA042205, HPA043013, HPA048671 Supported Approved Nucleoplasm
Cytosol Group enriched 6 bone marrow: 1.0;testis: 3.2 lymph node: 0.3 HIST1H3A H3/A, H3FA ENSG00000275714 Histone cluster 1, H3a 6 26020490-26020900 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA042570 Supported Group enriched 5 bone marrow: 6.7;epididymis: 1.8;testis: 3.7 cervix: 0.8 IFIT1B bA149I23.6, IFIT1L ENSG00000204010 Interferon-induced protein with tetratricopeptide repeats 1B 10 89378056-89385205 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA062924 Approved Group enriched 97 bone marrow: 15.3;placenta: 4.1 epididymis: 0.0 IGLL1 14.1, CD179B, IGL5, IGLL, IGVPB ENSG00000128322 Immunoglobulin lambda-like polypeptide 1 22 23573125-23580308 CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051134, HPA071406 Approved Approved Endoplasmic reticulum Group enriched 17 bone marrow: 44.3;testis: 16.1 tonsil: 1.7 LILRB3 CD85a, HL9, ILT5, LIR-3, LIR3 ENSG00000204577 Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 19 54216278-54223506 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 6 adipose tissue: 5.3;appendix: 10.4;bone marrow: 8.3;lung: 8.7;spleen: 9.4;urinary bladder: 6.9 placenta: 1.3 LIMD2 MGC10986 ENSG00000136490 LIM domain containing 2 17 63695902-63701172 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA062867 Approved Vesicles Group enriched 5 appendix: 145.1;bone marrow: 71.3;lymph node: 259.7;spleen: 195.3;tonsil: 145.7 urinary bladder: 31.4 MCEMP1 C19orf59, MGC132456 ENSG00000183019 Mast cell-expressed membrane protein 1 19 7676628-7679826 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014731 Supported Group enriched 9 appendix: 28.5;bone marrow: 43.9;lung: 110.4 smooth muscle: 6.9 NEU4 ENSG00000204099 Sialidase 4 2 241808825-241817413 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA037394, HPA037395 Uncertain Group enriched 7 bone marrow: 2.4;cerebral cortex: 6.4;colon: 8.5;duodenum: 5.7;liver: 4.1;rectum: 3.9;small intestine: 5.4 gallbladder: 0.8 NME8 CILD6, NM23-H8, SPTRX2, TXNDC3 ENSG00000086288 NME/NM23 family member 8 7 37848597-37900401 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB016416, HPA019259 Supported Group enriched 14 bone marrow: 8.2;testis: 18.3 spleen: 0.9 NTNG2 KIAA1857, Lmnt2, NTNG1 ENSG00000196358 Netrin G2 9 132161676-132244534 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA071290 Approved Group enriched 5 bone marrow: 26.5;cerebral cortex: 18.5;parathyroid gland: 16.0;prostate: 8.6 spleen: 3.2 PF4 CXCL4, SCYB4 ENSG00000163737 Platelet factor 4 4 73981077-73982124 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026008, HPA052485 Supported Group enriched 5 bone marrow: 53.9;spleen: 13.7 placenta: 6.4 S100A8 60B8AG, CAGA, CFAG, CGLA, MRP8, P8 ENSG00000143546 S100 calcium binding protein A8 1 153390032-153391188 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002791, HPA024372 Supported Supported Intermediate filaments Group enriched 9 bone marrow: 14952.4;esophagus: 12812.0;tonsil: 5078.4 appendix: 1261.4 S100A9 60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14 ENSG00000163220 S100 calcium binding protein A9 1 153357854-153361027 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004193, CAB009441 Supported Supported Nucleoplasm
Cell Junctions
Cytosol Group enriched 6 bone marrow: 21012.0;esophagus: 24343.4 tonsil: 4079.1 SEC14L4 dJ130H16.5, TAP3 ENSG00000133488 SEC14-like lipid binding 4 22 30488913-30505711 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA069748 Approved Centrosome Group enriched 8 bone marrow: 5.0;liver: 10.3;lung: 6.9;parathyroid gland: 10.3;testis: 7.1 adrenal gland: 0.9 SLC22A16 CT2, FLIPT2, OAT6, OKB1 ENSG00000004809 Solute carrier family 22 (organic cation/carnitine transporter), member 16 6 110424687-110476641 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA036902 Uncertain Group enriched 8 bone marrow: 13.0;parathyroid gland: 16.1;testis: 38.4 smooth muscle: 2.7 SNCA alpha-synuclein, NACP, PARK1, PARK4, PD1 ENSG00000145335 Synuclein, alpha (non A4 component of amyloid precursor) 4 89724099-89838315 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005459, CAB010877 Supported Group enriched 5 bone marrow: 161.2;cerebral cortex: 460.5 endometrium: 56.7 SPATC1 MGC61633, SPATA15, SPERIOLIN ENSG00000186583 Spermatogenesis and centriole associated 1 8 144012414-144047085 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA039590, HPA040220 Uncertain Group enriched 5 bone marrow: 6.2;testis: 21.8 appendix: 2.6 TRIM58 BIA2 ENSG00000162722 Tripartite motif containing 58 1 247857199-247878205 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA023637 Uncertain Group enriched 6 bone marrow: 16.2;placenta: 6.8;testis: 6.6;thyroid gland: 21.9 prostate: 2.0 TUBB1 dJ543J19.4 ENSG00000101162 Tubulin, beta 1 class VI 20 59019254-59026654 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004286, HPA043640, HPA046280 Approved Supported Microtubules Group enriched 5 bone marrow: 4.8;lung: 1.9;placenta: 1.2;spleen: 5.3;testis: 1.5 gallbladder: 0.5